CVE-2022-1521— 3.2.4 IMPROPER ACCESS CONTROL CWE-284
Quick assessment
Affected
Illumina NextSeq 550Dx
Exploitation
No confirmed in-the-wild exploitation; assess based on exposure
Recommended action
Check the vendor advisory and references for a fixed version. If immediate upgrade is impossible, restrict exposure and increase monitoring.
Illumina Local Run Manager（Illumina LRM）是美国Illumina公司的一种集成解决方案。旨在创建测序运行、监控运行状态、分析测序数据和查看结果。 Illumina Local Run Manager 存在访问控制错误漏洞，该漏洞源于访问限制不当。远程攻击者利用该漏洞可未经授权访问其他受限制的功能。以下产品和版本受到影响：In Vitro Diagnostic NextSeq 550Dx 所有版本、In Vitro Diagnostic MiSeq Dx 所有版本、Ne
Possible ATT&CK Techniques 3 AI
T1059 · Command and Scripting Interpreter T1071 · Application Layer Protocol T1190 · Exploit Public-Facing Application
Get alerts for future matching vulnerabilities
Log in to subscribe
I. Basic Information for CVE-2022-1521
Vulnerability Information
Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗
Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.
Vulnerability Title
3.2.4 IMPROPER ACCESS CONTROL CWE-284
Source: CVE Program / CVE List V5
Vulnerability Description
LRM does not implement authentication or authorization by default. A malicious actor can inject, replay, modify, and/or intercept sensitive data.
Source: CVE Program / CVE List V5
CVSS Information
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
Source: CVE Program / CVE List V5
Vulnerability Type
访问控制不恰当
Source: CVE Program / CVE List V5
Vulnerability Title
Illumina Local Run Manager 访问控制错误漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Illumina Local Run Manager（Illumina LRM）是美国Illumina公司的一种集成解决方案。旨在创建测序运行、监控运行状态、分析测序数据和查看结果。 Illumina Local Run Manager 存在访问控制错误漏洞，该漏洞源于访问限制不当。远程攻击者利用该漏洞可未经授权访问其他受限制的功能。以下产品和版本受到影响：In Vitro Diagnostic NextSeq 550Dx 所有版本、In Vitro Diagnostic MiSeq Dx 所有版本、Ne
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
| Vendor | Product | Affected Versions | CPE | Subscribe |
|---|---|---|---|---|
| Illumina | NextSeq 550Dx | LRM Versions 1.3 to 3.1 | - |
|
| Illumina | MiSeq Dx | LRM Versions 1.3 to 3.1 | - |
|
| Illumina | NextSeq 500 Instrumen | LRM Versions 1.3 to 3.1 | - |
|
| Illumina | NextSeq 550 Instrument | LRM Versions 1.3 to 3.1 | - |
|
| Illumina | MiSeq Instrument | LRM Versions 1.3 to 3.1 | - |
|
| Illumina | iSeq 100 Instrument | LRM Versions 1.3 to 3.1 | - |
|
| Illumina | MiniSeq Instrument | LRM Versions 1.3 to 3.1 | - |
|
II. Public POCs for CVE-2022-1521
| # | POC Description | Source Link | Shenlong Link |
|---|
AI-Generated POC
Premium
No public POC found.
Login to generate AI POCIII. Intelligence Information for CVE-2022-1521
请登录查看更多情报信息。
Vendor Advisories for CVE-2022-1521 (1)
-
https://www.cisa.gov/uscert/ics/advisories/icsa-22-153-02 x_refsource_MISC
Same Patch Batch · Illumina · 2022-06-24 · 5 CVEs total
| CVE-2022-1517 | 10.0 CRITICAL | 3.2.1 EXECUTION WITH UNNECESSARY PRIVILEGES CWE-250 |
| CVE-2022-1518 | 10.0 CRITICAL | 3.2.2 IMPROPER LIMITATION OF A PATHNAME TO A RESTRICTED DIRECTORY ('PATH TRAVERSAL') CW |
| CVE-2022-1519 | 10.0 CRITICAL | Illumina Local Run Manager 代码问题漏洞 |
| CVE-2022-1524 | 7.4 HIGH | 3.2.5 CLEARTEXT TRANSMISSION OF SENSITIVE INFORMATION CWE-319 |
IV. Related Vulnerabilities
Same weakness: CWE-284
-
CVE-2026-105823
ImageMagick before 7.1.2-31 Policy Bypass in CUT Encoder -
CVE-2026-76281
Improper Access Control in Splunk Enterprise -
CVE-2026-76265
Improper Access Control through REST API Endpoints in Splunk -
CVE-2026-76463
Cisco Meraki Security Hardening Release: October 2026 - Impr -
CVE-2026-76498
Cisco Application Policy Infrastructure Controller Hardening
V. Comments for CVE-2022-1521
No comments yet